JP2008535491A5 - - Google Patents

Download PDF

Info

Publication number
JP2008535491A5
JP2008535491A5 JP2008505525A JP2008505525A JP2008535491A5 JP 2008535491 A5 JP2008535491 A5 JP 2008535491A5 JP 2008505525 A JP2008505525 A JP 2008505525A JP 2008505525 A JP2008505525 A JP 2008505525A JP 2008535491 A5 JP2008535491 A5 JP 2008535491A5
Authority
JP
Japan
Prior art keywords
cancer
antibody
ptpε
expression
gene
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2008505525A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008535491A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2006/012863 external-priority patent/WO2006110466A2/en
Publication of JP2008535491A publication Critical patent/JP2008535491A/ja
Publication of JP2008535491A5 publication Critical patent/JP2008535491A5/ja
Withdrawn legal-status Critical Current

Links

JP2008505525A 2005-04-07 2006-04-07 癌に関連した遺伝子（ＰＴＰε） Withdrawn JP2008535491A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US66985605P 2005-04-07 2005-04-07
US78492506P 2006-03-22 2006-03-22
PCT/US2006/012863 WO2006110466A2 (en) 2005-04-07 2006-04-07 CANCER-RELATED GENES (PTPϵ)

Publications (2)

Publication Number Publication Date
JP2008535491A JP2008535491A (ja) 2008-09-04
JP2008535491A5 true JP2008535491A5 (enExample) 2009-04-02

Family

ID=37022876

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008505525A Withdrawn JP2008535491A (ja) 2005-04-07 2006-04-07 癌に関連した遺伝子（ＰＴＰε）

Country Status (4)

Country Link
US (1) US20090317391A1 (enExample)
EP (1) EP1874959A2 (enExample)
JP (1) JP2008535491A (enExample)
WO (1) WO2006110466A2 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20080085080A (ko) * 2006-01-04 2008-09-22 노파르티스 아게 항체-의존성 세포 세포독성 분석법
BRPI0821417A2 (pt) 2007-12-26 2015-06-16 Biotest Ag Método para diminuir a adesão de células de estroma a células tumorais que expressam cd138 em células tumorais de um indivíduo em necessidade do mesmo
JP5817034B2 (ja) * 2007-12-26 2015-11-18 バイオテスト・アクチエンゲゼルシヤフト Ｃｄ１３８を標的とする免疫複合体及びその使用
US9221914B2 (en) 2007-12-26 2015-12-29 Biotest Ag Agents targeting CD138 and uses thereof
US8512944B2 (en) * 2008-08-27 2013-08-20 Oncotherapy Science, Inc. PRMT1 for target genes of cancer therapy and diagnosis
WO2017196810A1 (en) 2016-05-10 2017-11-16 Medimmune, Llc Prevention of protein disulfide bond reduction

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1285970A3 (en) * 2001-06-26 2004-05-19 National Taiwan University Metastasis-associated genes
US20030225026A1 (en) * 2002-05-13 2003-12-04 Ari Elson Methods, compositions and articles of manufacture useful for treating mammary tumors

Similar Documents

Publication Publication Date Title
JP2008535494A5 (enExample)
Onitsuka et al. Comprehensive molecular analyses of lung adenocarcinoma with regard to the epidermal growth factor receptor, K-ras, MET, and hepatocyte growth factor status
CN109790582B (zh) 基于c-maf状态的乳腺癌治疗性治疗
KR20150122731A (ko) 암 전이의 예후 및 치료 방법
CN106662543B (zh) 肺癌患者中的非侵入性基因突变检测
Yin et al. Netrin-1 promotes cell neural invasion in gastric cancer via its receptor neogenin
JP2023533873A (ja) 癌用の予後バイオマーカー
JP4759612B2 (ja) 癌治療化合物のｉｎ ｖｉｔｒｏにおける同定方法
JP2008535856A5 (enExample)
JP2008535491A5 (enExample)
ITCH20120008A1 (it) Uso di trop-2 come marcatore predittivo di risposta a terapia anti-tumorale basata su inibitori di cd9, akt e vie di segnale collegate
CN102947446A (zh) 肺腺癌的预后预测方法、肺腺癌的检测试剂盒以及用于治疗肺腺癌的医药组合物
JP2008535855A5 (enExample)
CN117129690B (zh) Grhl1在her2-乳腺癌诊断及预后评估中的应用
Zhang et al. Cathepsin a upregulation in glioma: A potential therapeutic target associated with immune infiltration
EP2966448B1 (en) Method for the prediction or prognosis of the response of a human subject suffering from cancer to treatment with an antagonist of the nk1 receptor
Liu et al. STMN1 as a candidate gene associated with atypical meningioma progression
JP2008535854A5 (enExample)
CA2992377A1 (en) Method for individualized cancer therapy
WO2010131080A1 (en) A method for predicting the therapeutic responsiveness of a patient to a medical treatment with an egfr inhibitor
JP7774310B2 (ja) 腎がん患者の抗がん剤抵抗性および予後予測方法、抗腎がん物質のスクリーニング方法、ならびに、腎がん治療用医薬組成物
EP2702409B1 (en) CXCR1 as a predictor of response to treatment with epidermal growth factor receptor targeted therapeutic
JP6175711B2 (ja) Ｓ−１による癌化学療法の投与効果の判定方法
CA2742512A1 (en) Method for optimizing the treatment of chronic myeloid leukemia with abl tyrosine kinase inhibitors
TW202417839A (zh) 作為癌症治療之標記及標靶的chrm3